Table 3.

Multivariable model of factors associated with suicidal ideation

Covariate	OR	95% CI	p
Age	0.98	0.97, 0.99	< 0.001
Sex	0.91	0.74, 1.11	0.34
MAT	1.02	0.80, 1.31	0.85
Dose	1.00	1.00, 1.00	0.24
Years in Treatment	0.97	0.95, 1.00	0.02
Have access to naloxone kits	1.60	1.23, 2.08	< 0.001
Total physical symptoms score on MAP	1.08	1.06, 1.09	< 0.001
Alcohol Use (past 30 days)	1.21	0.99, 1.48	0.07
Prescription benzodiazepine use	1.69	1.32, 2.18	< 0.001
Non-prescription use of benzodiazepines (past 30 days)	2.35	1.70, 3.25	< 0.001
Opioid abstinence at baseline	0.68	0.54, 0.85	0.001

OR Odds ratio, CI confidence interval, MAT medication-assisted treatment, MAP Maudsley Addiction Profile